Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal

Fabrizis Suarez, Michael D. Levitt, Jacqueline Adshead, Jamie S Barkin

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

In a double-blind, crossover study, we determined whether microencapusulated pancreatic enzymes reduce postprandial symptoms experienced by healthy volunteers after ingestion of a high calorie, high fat meal. At 7 AM, 18 subjects ingested 185 g of cookies (1196 calories and 72 g of fat) with three pancrelipase capsules or a placebo. The severity of gastrointestinal symptoms and flatus passages were recorded for 15-17 hr, and end-alveolar samples were obtained hourly for 10 hr. Ingestion of pancreatic supplements was associated with a significant (P = 0.049) reduction in bloating over the entire recording period, and with significant reductions in bloating, gas, and fullness during the dinner to bedtime period. Pancreatic supplements had no significant effect on breath H2 or CH4 concentration. The finding that pancreatic supplements reduce postprandial symptoms in healthy subjects suggests that these supplements also might be beneficial in irritable bowel syndrome.

Original languageEnglish
Pages (from-to)1317-1321
Number of pages5
JournalDigestive Diseases and Sciences
Volume44
Issue number7
DOIs
StatePublished - Sep 3 1999

Fingerprint

Meals
Healthy Volunteers
Pancrelipase
Eating
Fats
Flatulence
Irritable Bowel Syndrome
Double-Blind Method
Cross-Over Studies
Capsules
Gases
Placebos
Enzymes

Keywords

  • Breath hydrogen
  • Gastrointestinal symptoms
  • Pancreatic enzymes

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. / Suarez, Fabrizis; Levitt, Michael D.; Adshead, Jacqueline; Barkin, Jamie S.

In: Digestive Diseases and Sciences, Vol. 44, No. 7, 03.09.1999, p. 1317-1321.

Research output: Contribution to journalArticle

Suarez, Fabrizis ; Levitt, Michael D. ; Adshead, Jacqueline ; Barkin, Jamie S. / Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal. In: Digestive Diseases and Sciences. 1999 ; Vol. 44, No. 7. pp. 1317-1321.
@article{2ef3c0d4ae764e8c804f83580db86c56,
title = "Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal",
abstract = "In a double-blind, crossover study, we determined whether microencapusulated pancreatic enzymes reduce postprandial symptoms experienced by healthy volunteers after ingestion of a high calorie, high fat meal. At 7 AM, 18 subjects ingested 185 g of cookies (1196 calories and 72 g of fat) with three pancrelipase capsules or a placebo. The severity of gastrointestinal symptoms and flatus passages were recorded for 15-17 hr, and end-alveolar samples were obtained hourly for 10 hr. Ingestion of pancreatic supplements was associated with a significant (P = 0.049) reduction in bloating over the entire recording period, and with significant reductions in bloating, gas, and fullness during the dinner to bedtime period. Pancreatic supplements had no significant effect on breath H2 or CH4 concentration. The finding that pancreatic supplements reduce postprandial symptoms in healthy subjects suggests that these supplements also might be beneficial in irritable bowel syndrome.",
keywords = "Breath hydrogen, Gastrointestinal symptoms, Pancreatic enzymes",
author = "Fabrizis Suarez and Levitt, {Michael D.} and Jacqueline Adshead and Barkin, {Jamie S}",
year = "1999",
month = "9",
day = "3",
doi = "10.1023/A:1026675012864",
language = "English",
volume = "44",
pages = "1317--1321",
journal = "Digestive Diseases and Sciences",
issn = "0163-2116",
publisher = "Plenum Publishers",
number = "7",

}

TY - JOUR

T1 - Pancreatic supplements reduce symptomatic response of healthy subjects to a high fat meal

AU - Suarez, Fabrizis

AU - Levitt, Michael D.

AU - Adshead, Jacqueline

AU - Barkin, Jamie S

PY - 1999/9/3

Y1 - 1999/9/3

N2 - In a double-blind, crossover study, we determined whether microencapusulated pancreatic enzymes reduce postprandial symptoms experienced by healthy volunteers after ingestion of a high calorie, high fat meal. At 7 AM, 18 subjects ingested 185 g of cookies (1196 calories and 72 g of fat) with three pancrelipase capsules or a placebo. The severity of gastrointestinal symptoms and flatus passages were recorded for 15-17 hr, and end-alveolar samples were obtained hourly for 10 hr. Ingestion of pancreatic supplements was associated with a significant (P = 0.049) reduction in bloating over the entire recording period, and with significant reductions in bloating, gas, and fullness during the dinner to bedtime period. Pancreatic supplements had no significant effect on breath H2 or CH4 concentration. The finding that pancreatic supplements reduce postprandial symptoms in healthy subjects suggests that these supplements also might be beneficial in irritable bowel syndrome.

AB - In a double-blind, crossover study, we determined whether microencapusulated pancreatic enzymes reduce postprandial symptoms experienced by healthy volunteers after ingestion of a high calorie, high fat meal. At 7 AM, 18 subjects ingested 185 g of cookies (1196 calories and 72 g of fat) with three pancrelipase capsules or a placebo. The severity of gastrointestinal symptoms and flatus passages were recorded for 15-17 hr, and end-alveolar samples were obtained hourly for 10 hr. Ingestion of pancreatic supplements was associated with a significant (P = 0.049) reduction in bloating over the entire recording period, and with significant reductions in bloating, gas, and fullness during the dinner to bedtime period. Pancreatic supplements had no significant effect on breath H2 or CH4 concentration. The finding that pancreatic supplements reduce postprandial symptoms in healthy subjects suggests that these supplements also might be beneficial in irritable bowel syndrome.

KW - Breath hydrogen

KW - Gastrointestinal symptoms

KW - Pancreatic enzymes

UR - http://www.scopus.com/inward/record.url?scp=0032815435&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032815435&partnerID=8YFLogxK

U2 - 10.1023/A:1026675012864

DO - 10.1023/A:1026675012864

M3 - Article

C2 - 10489912

AN - SCOPUS:0032815435

VL - 44

SP - 1317

EP - 1321

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

SN - 0163-2116

IS - 7

ER -